Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Accounts Payables (2021 - 2025)

Historic Accounts Payables for Core Scientific (CORZ) over the last 5 years, with Q3 2025 value amounting to $212.2 million.

  • Core Scientific's Accounts Payables rose 316228.47% to $212.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $212.2 million, marking a year-over-year increase of 316228.47%. This contributed to the annual value of $19.3 million for FY2024, which is 8755.1% down from last year.
  • Core Scientific's Accounts Payables amounted to $212.2 million in Q3 2025, which was up 316228.47% from $215.1 million recorded in Q2 2025.
  • Core Scientific's 5-year Accounts Payables high stood at $215.1 million for Q2 2025, and its period low was $86179.0 during Q1 2021.
  • In the last 5 years, Core Scientific's Accounts Payables had a median value of $19.3 million in 2024 and averaged $49.8 million.
  • Per our database at Business Quant, Core Scientific's Accounts Payables surged by 1802854.64% in 2022 and then plummeted by 8755.1% in 2024.
  • Core Scientific's Accounts Payables (Quarter) stood at $11.6 million in 2021, then skyrocketed by 361.75% to $53.6 million in 2022, then soared by 188.49% to $154.8 million in 2023, then tumbled by 87.55% to $19.3 million in 2024, then skyrocketed by 1001.37% to $212.2 million in 2025.
  • Its Accounts Payables stands at $212.2 million for Q3 2025, versus $215.1 million for Q2 2025 and $6.3 million for Q1 2025.